Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

(68)Ga-AMBA and (18)F-FDG for preclinical PET imaging of breast cancer: effect of tamoxifen treatment on tracer uptake by tumor.

Prignon A, Nataf V, Provost C, Cagnolini A, Montravers F, Gruaz-Guyon A, Lantry LE, Talbot JN, Nunn AD.

Nucl Med Biol. 2015 Feb;42(2):92-8. doi: 10.1016/j.nucmedbio.2014.10.003. Epub 2014 Oct 13.

PMID:
25459112
2.

Automated synthesis, characterization and biological evaluation of [(68)Ga]Ga-AMBA, and the synthesis and characterization of (nat)Ga-AMBA and [(67)Ga]Ga-AMBA.

Cagnolini A, Chen J, Ramos K, Skedzielewski TM, Lantry LE, Nunn AD, Swenson RE, Linder KE.

Appl Radiat Isot. 2010 Dec;68(12):2285-92. doi: 10.1016/j.apradiso.2010.06.023. Epub 2010 Jun 30.

PMID:
20638858
3.

177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.

Maddalena ME, Fox J, Chen J, Feng W, Cagnolini A, Linder KE, Tweedle MF, Nunn AD, Lantry LE.

J Nucl Med. 2009 Dec;50(12):2017-24. doi: 10.2967/jnumed.109.064444. Epub 2009 Nov 12.

4.

In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites.

Linder KE, Metcalfe E, Arunachalam T, Chen J, Eaton SM, Feng W, Fan H, Raju N, Cagnolini A, Lantry LE, Nunn AD, Swenson RE.

Bioconjug Chem. 2009 Jun;20(6):1171-8. doi: 10.1021/bc9000189.

PMID:
19480415
5.

In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues.

Thomas R, Chen J, Roudier MM, Vessella RL, Lantry LE, Nunn AD.

Clin Exp Metastasis. 2009;26(2):105-19. doi: 10.1007/s10585-008-9220-0. Epub 2008 Oct 31.

PMID:
18975117
6.
7.

177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.

Lantry LE, Cappelletti E, Maddalena ME, Fox JS, Feng W, Chen J, Thomas R, Eaton SM, Bogdan NJ, Arunachalam T, Reubi JC, Raju N, Metcalfe EC, Lattuada L, Linder KE, Swenson RE, Tweedle MF, Nunn AD.

J Nucl Med. 2006 Jul;47(7):1144-52.

8.

Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.

Zhang Z, Wang Y, Lantry LE, Kastens E, Liu G, Hamilton AD, Sebti SM, Lubet RA, You M.

Oncogene. 2003 Sep 18;22(40):6257-65.

PMID:
13679864
9.

p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas.

Zhang Z, Li J, Lantry LE, Wang Y, Wiseman RW, Lubet RA, You M.

Cancer Res. 2002 Jun 1;62(11):3024-9.

10.

Chemopreventive efficacy of promising farnesyltransferase inhibitors.

Lantry LE, Zhang Z, Crist KA, Wang Y, Hara M, Zeeck A, Lubet RA, You M.

Exp Lung Res. 2000 Dec;26(8):773-90.

PMID:
11195470
11.
12.

Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Lantry LE, Zhang Z, Yao R, Crist KA, Wang Y, Ohkanda J, Hamilton AD, Sebti SM, Lubet RA, You M.

Carcinogenesis. 2000 Jan;21(1):113-6.

PMID:
10607742
13.

Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis.

Herzog CR, Noh S, Lantry LE, Guan KL, You M.

Mol Carcinog. 1999 Jun;25(2):92-8.

PMID:
10365910
14.

5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model.

Lantry LE, Zhang Z, Crist KA, Wang Y, Kelloff GJ, Lubet RA, You M.

Carcinogenesis. 1999 Feb;20(2):343-6.

PMID:
10069475
15.

Cytotoxicity of tocopherols and their quinones in drug-sensitive and multidrug-resistant leukemia cells.

Cornwell DG, Jones KH, Jiang Z, Lantry LE, Southwell-Keely P, Kohar I, Thornton DE.

Lipids. 1998 Mar;33(3):295-301.

PMID:
9560804
16.

Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung.

Lantry LE, Zhang Z, Gao F, Crist KA, Wang Y, Kelloff GJ, Lubet RA, You M.

J Cell Biochem Suppl. 1997;27:20-5.

PMID:
9591189
17.

Substance P and neurokinin A metabolism by cultured human skeletal muscle myocytes and fibroblasts.

Russell JS, Chi H, Lantry LE, Stephens RE, Ward PE.

Peptides. 1996;17(8):1397-403.

PMID:
8971937
18.

Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation.

Hanna AN, Titterington LC, Lantry LE, Stephens RE, Newman HA.

Biochem Pharmacol. 1995 Nov 9;50(10):1627-33.

PMID:
7503765
19.

Correlation between AIDS-related Kaposi sarcoma histological grade and in vitro behavior: reduced exogenous growth factor requirements for isolates from high grade lesions.

Bailer RT, Lazo A, Ng-Bautista CL, Hout BL, Ness GM, Hegtvedt AK, Lantry LE, Blakeslee JR, Stephens RE, Brierley GP, et al.

Lymphology. 1995 Sep;28(3):126-37.

PMID:
7475261
20.

Angiotensin and bradykinin metabolism by peptidases identified in cultured human skeletal muscle myocytes and fibroblasts.

Vaghy PL, Russell JS, Lantry LE, Stephens RE, Ward PE.

Peptides. 1995;16(8):1367-73.

PMID:
8745045
21.

Human microvascular endothelial cell-extracellular matrix interaction in cellular growth state determination.

Mallery SR, Lantry LE, Toms MC, Titterington LC, Hout BL, Brierley GP, Stephens RE.

Cell Tissue Res. 1995 Jan;279(1):37-45.

PMID:
7895263
22.

Cultured AIDS-related Kaposi's sarcoma cells retain a proliferative bioenergetic profile but demonstrate reduced cytoprotective capabilities.

Mallery SR, Ng-Bautista CL, Lantry LE, Ness GM, Hegtvedt AK, Lazo A, Bailer RT, Hout BL, Stephens RE, Brierley GP.

J Cell Biochem. 1994 Dec;56(4):568-81.

PMID:
7890815
23.

Environmental induction of tumor phenotype in a putative Kaposi sarcoma progenitor cell.

Mallery SR, Lantry LE, Hegtvedt A, Lazo A, Titterington LC, Hout BL, Brierley GP, Stephens RE.

Lymphology. 1994 Mar;27(1):45-8.

PMID:
8207969
24.

Modulation of human microvascular endothelial cell bioenergetic status and glutathione levels during proliferative and differentiated growth.

Mallery SR, Lantry LE, Laufman HB, Stephens RE, Brierley GP.

J Cell Biochem. 1993 Dec;53(4):360-72.

PMID:
8300753
25.

Determination of DNA superhelicity and extremely low levels of DNA strand breaks in low numbers of nonradiolabeled cells by DNA-4',6-diamidino-2-phenylindole fluorescence in nucleoid gradients.

Lipetz PD, Brash DE, Joseph LB, Jewett HD, Lisle DR, Lantry LE, Hart RW, Stephens RE.

Anal Biochem. 1982 Apr;121(2):339-48. No abstract available.

PMID:
7103066

Supplemental Content

Loading ...
Support Center